Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04656652 · FLOW

Participant flow

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) · Source last updated 2026-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants were randomized to receive 6.0 mg/kg of DS-1062a.
    id
    FG000
    title
    DS-1062a 6.0 mg/kg
  2. description
    Participants were randomized to receive 75 mg/m\^2 docetaxel.
    id
    FG001
    title
    Docetaxel 75 mg/m^2
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        213
      2. group Id
        FG001
        num Subjects
        212
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Other
    4. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        29
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        299
      2. group Id
        FG001
        num Subjects
        305
      comment
      "Started" signifies number of participants randomized
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        68
      2. group Id
        FG001
        num Subjects
        62
      comment
      "Complete" signifies number of participants ongoing in study
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        231
      2. group Id
        FG001
        num Subjects
        243
      type
      NOT COMPLETED
    title
    Overall Study
recruitment Details
A total of 605 participants , including 1 participant who was randomized twice, were randomized to the study in Europe, Asia, North America, South America, and Australia.
Complete source fields
groups
  1. description
    Participants were randomized to receive 6.0 mg/kg of DS-1062a.
    id
    FG000
    title
    DS-1062a 6.0 mg/kg
  2. description
    Participants were randomized to receive 75 mg/m\^2 docetaxel.
    id
    FG001
    title
    Docetaxel 75 mg/m^2
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        213
      2. group Id
        FG001
        num Subjects
        212
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Other
    4. reasons
      1. group Id
        FG000
        num Subjects
        15
      2. group Id
        FG001
        num Subjects
        29
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        299
      2. group Id
        FG001
        num Subjects
        305
      comment
      "Started" signifies number of participants randomized
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        68
      2. group Id
        FG001
        num Subjects
        62
      comment
      "Complete" signifies number of participants ongoing in study
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        231
      2. group Id
        FG001
        num Subjects
        243
      type
      NOT COMPLETED
    title
    Overall Study
recruitment Details
A total of 605 participants , including 1 participant who was randomized twice, were randomized to the study in Europe, Asia, North America, South America, and Australia.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice